These results demonstrate that IL1 signalling in breast cancer cells has different effects on metastasis to different metastatic niches; IL-1 is strongly pro-metastatic towards bone cells but anti-metastatic towards endothelial cells. This evidence concerns the gene IL1B and breast carcinoma.